FDA’s Tidmarsh Exits Amid ‘Personal Conduct’ Probe
www.biospace.com
George Tidmarsh, who helmed the FDA’s Center for Drug Evaluation and Research, resigned Sunday following a complaint by biopharma investor Kevin Tang, whose affiliated company, Aurinia Pharmaceuticals, filed a lawsuit against the former regulator on Sunday.

Trump hire George Tidmarsh turfed from FDA amid allegations of soliciting bribes from Aurinia. And the same day this is announced, the FDA says they are no longer aligned with UniQure on that safety trial for a Huntington’s disease therapy massively hyped in September as a “cure”. Shirley a coincidence.

“Secretary Kennedy expects the highest ethical standards from all individuals serving under his leadership and remains committed to full transparency,” a health department spokesperson told STAT in a statement on Sunday.

Gold!